Oxidative stress-dependent phosphorylation activates ZNRF1 to induce neuronal/axonal degeneration

Journal of Cell Biology

Volumn 211, Issue 4, 2015, Pages 881-896

  Wakatsuki, Shuji ^a   Furuno, Akiko ^a   Ohshima, Makiko ^b   Araki, Toshiyuki ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; PROTEIN KINASE B; TYROSINE; UBIQUITIN PROTEIN LIGASE E3; UNCLASSIFIED DRUG; ZNRF1 PROTEIN; EGFR PROTEIN, MOUSE; UBIQUITIN PROTEIN LIGASE; ZNRF1 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL CELL CULTURE; APOPTOSIS; ARTICLE; ENZYME ACTIVATION; ENZYME ACTIVITY; IN VITRO STUDY; MOUSE; NERVE CELL CULTURE; NERVE CELL DEGENERATION; NERVE CELL LESION; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RECEPTOR UPREGULATION; UBIQUITINATION; WALLERIAN DEGENERATION; ANIMAL; C57BL MOUSE; CELL CULTURE; CEREBRAL ARTERY DISEASE; DOPAMINERGIC NERVE CELL; ENZYMOLOGY; MALE; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PHOSPHORYLATION; PROTEIN DEGRADATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION;

ANIMALS; CELLS, CULTURED; DOPAMINERGIC NEURONS; ENZYME ACTIVATION; INFARCTION, MIDDLE CEREBRAL ARTERY; MALE; MICE, INBRED C57BL; MOLECULAR SEQUENCE DATA; OXIDATIVE STRESS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEOLYSIS; PROTO-ONCOGENE PROTEINS C-AKT; RECEPTOR, EPIDERMAL GROWTH FACTOR; SIGNAL TRANSDUCTION; UBIQUITIN-PROTEIN LIGASES; WALLERIAN DEGENERATION;

EID: 84964741392     PISSN: 00219525     EISSN: 15408140     Source Type: Journal    
DOI: 10.1083/jcb.201506102     Document Type: Article

References (47)

1. Araki, T., and J. Milbrandt. 2003. ZNRF proteins constitute a family of presynaptic E3 ubiquitin ligases. J. Neurosci. 23:9385-9394
2. Araki, T., Y. Sasaki, and J. Milbrandt. 2004. Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration. Science. 305:1010-1013. http://dx.doi.org/10.1126/science.1098014
3. Barnham, K.J., C.L. Masters, and A.I. Bush. 2004. Neurodegenerative diseases and oxidative stress. Nat. Rev. Drug Discov. 3:205-214. http://dx.doi.org/10.1038/nrd1330
4. Bedard, K., and K.H. Krause. 2007. The NOX family of ROS-generating NAD PH oxidases: physiology and pathophysiology. Physiol. Rev. 87:245-313. http://dx.doi.org/10.1152/physrev.00044.2005
5. Blandini, F., and M.T. Armentero. 2012. Animal models of Parkinson's disease. FEBS J. 279:1156-1166. http://dx.doi.org/10.1111/j.1742-4658.2012.08491.x
6. Broughton, B.R., D.C. Reutens, and C.G. Sobey. 2009. Apoptotic mechanisms after cerebral ischemia. Stroke. 40:e331-e339. http://dx.doi.org/10.1161/STROKEAHA.108.531632
7. Calixto, A., J.S. Jara, and F.A. Court. 2012. Diapause formation and downregulation of insulin-like signaling via DAF-16/FOXO delays axonal degeneration and neuronal loss. PLoS Genet. 8:e1003141. http://dx.doi.org/10.1371/journal.pgen.1003141
8. Chen, M., J.A. Maloney, D.Y. Kallop, J.K. Atwal, S.J. Tam, K. Baer, H. Kissel, J.S. Kaminker, J.W. Lewcock, R.M. Weimer, and R.J. Watts. 2012. Spatially coordinated kinase signaling regulates local axon degeneration. J. Neurosci. 32:13439-13453. http://dx.doi.org/10.1523/JNEUROSCI.2039-12.2012
9. Cheng, H.C., S.R. Kim, T.F. Oo, T. Kareva, O. Yarygina, M. Rzhetskaya, C. Wang, M. During, Z. Talloczy, K. Tanaka, et al. 2011. Akt suppresses retrograde degeneration of dopaminergic axons by inhibition of macroautophagy. J. Neurosci. 31:2125-2135. http://dx.doi.org/10.1523/JNEUROSCI.5519-10.2011
10. Cole, A.R., W. Noble, L. van Aalten, F. Plattner, R. Meimaridou, D. Hogan, M. Taylor, J. LaFrancois, F. Gunn-Moore, A. Verkhratsky, et al. 2007. Collapsin response mediator protein-2 hyperphosphorylation is an early event in Alzheimer's disease progression. J. Neurochem. 103:1132-1144. http://dx.doi.org/10.1111/j.1471-4159.2007.04829.x
11. Coleman, M. 2005. Axon degeneration mechanisms: Commonality amid diversity. Nat. Rev. Neurosci. 6:889-898. http://dx.doi.org/10.1038/nrn1788
12. Coleman, M.P., and M.R. Freeman. 2010. Wallerian degeneration, wld(s), and nmnat. Annu. Rev. Neurosci. 33:245-267. http://dx.doi.org/10.1146/annurev-neuro-060909-153248
13. Conner, D.A. 2004. Transgenic mouse production by zygote injection. In Current Protocols in Molecular Biology. John Wiley & Sons Inc., New York
14. Cormack, B. 2001. Directed mutagenesis using the polymerase chain reaction. In Current Protocols in Molecular Biology. John Wiley & Sons Inc., New York
15. Elmore, S. 2007. Apoptosis: A review of programmed cell death. Toxicol. Pathol. 35:495-516. http://dx.doi.org/10.1080/01926230701320337
16. Finn, J.T., M. Weil, F. Archer, R. Siman, A. Srinivasan, and M.C. Raff. 2000. Evidence that Wallerian degeneration and localized axon degeneration induced by local neurotrophin deprivation do not involve caspases. J. Neurosci. 20:1333-1341
17. Gallagher, E., M. Gao, Y.C. Liu, and M. Karin. 2006. Activation of the E3 ubiquitin ligase Itch through a phosphorylation-induced conformational change. Proc. Natl. Acad. Sci. USA. 103:1717-1722. http://dx.doi.org/10.1073/pnas.0510664103
18. Gandhi, S., and A.Y. Abramov. 2012. Mechanism of oxidative stress in neurodegeneration. Oxid. Med. Cell. Longev. 2012:428010. http://dx.doi.org/10.1155/2012/428010
19. Gerdts, J., Y. Sasaki, B. Vohra, J. Marasa, and J. Milbrandt. 2011. Image-based screening identifies novel roles for IκB kinase and glycogen synthase kinase 3 in axonal degeneration. J. Biol. Chem. 286:28011-28018. http://dx.doi.org/10.1074/jbc.M111.250472
20. Gerdts, J., D.W. Summers, Y. Sasaki, A. DiAntonio, and J. Milbrandt. 2013. Sarm1-mediated axon degeneration requires both SAM and TIR interactions. J. Neurosci. 33:13569-13580. http://dx.doi.org/10.1523/JNEUROSCI.1197-13.2013
21. Gerdts, J., E.J. Brace, Y. Sasaki, A. DiAntonio, and J. Milbrandt. 2015. SARM1 activation triggers axon degeneration locally via NAD+ destruction. Science. 348:453-457. http://dx.doi.org/10.1126/science.1258366
22. Grünblatt, E., S. Mandel, and M.B. Youdim. 2000. Neuroprotective strategies in Parkinson's disease using the models of 6-hydroxydopamine and MPTP. Ann. N. Y. Acad. Sci. 899:262-273. http://dx.doi.org/10.1111/j.1749-6632.2000.tb06192.x
23. Guégan, C., B. Onténiente, Y. Makiura, M. Merad-Boudia, I. Ceballos-Picot, and B. Sola. 1998. Reduction of cortical infarction and impairment of apoptosis in NGF-transgenic mice subjected to permanent focal ischemia. Brain Res. Mol. Brain Res. 55:133-140. http://dx.doi.org/10.1016/S0169-328X(97)00372-0
24. Hou, S.T., S.X. Jiang, A. Aylsworth, G. Ferguson, J. Slinn, H. Hu, T. Leung, J. Kappler, and K. Kaibuchi. 2009. CaMKII phosphorylates collapsin response mediator protein 2 and modulates axonal damage during glutamate excitotoxicity. J. Neurochem. 111:870-881. http://dx.doi.org/10.1111/j.1471-4159.2009.06375.x
25. Hoxhaj, G., A. Najafov, R. Toth, D.G. Campbell, A.R. Prescott, and C. MacKintosh. 2012. ZNRF2 is released from membranes by growth factors and, together with ZNRF1, regulates the Na+/K+ATPase. J. Cell Sci. 125:4662-4675. http://dx.doi.org/10.1242/jcs.110296
26. Kazlauskaite, A., V. Kelly, C. Johnson, C. Baillie, C.J. Hastie, M. Peggie, T. Macartney, H.I. Woodroof, D.R. Alessi, P.G. Pedrioli, and M.M. Muqit. 2014. Phosphorylation of Parkin at Serine65 is essential for activation: Elaboration of a Miro1 substrate-based assay of Parkin E3 ligase activity. Open Biol. 4:130213. http://dx.doi.org/10.1098/rsob.130213
27. Kinoshita, E., E. Kinoshita-Kikuta, K. Takiyama, and T. Koike. 2006. Phosphate-binding tag, a new tool to visualize phosphorylated proteins. Mol. Cell. Proteomics. 5:749-757. http://dx.doi.org/10.1074/mcp.T500024-MCP200
28. Li, Y., T. Perry, M.S. Kindy, B.K. Harvey, D. Tweedie, H.W. Holloway, K. Powers, H. Shen, J.M. Egan, K. Sambamurti, et al. 2009. GLP-1 receptor stimulation preserves primary cortical and dopaminergic neurons in cellular and rodent models of stroke and Parkinsonism. Proc. Natl. Acad. Sci. USA. 106:1285-1290. http://dx.doi.org/10.1073/pnas.0806720106
29. Lobner, D. 2000. Comparison of the LDH and MTT assays for quantifying cell death: Validity for neuronal apoptosis? J. Neurosci. Methods. 96:147-152. http://dx.doi.org/10.1016/S0165-0270(99)00193-4
30. Masuyama, N., K. Oishi, Y. Mori, T. Ueno, Y. Takahama, and Y. Gotoh. 2001. Akt inhibits the orphan nuclear receptor Nur77 and T-cell apoptosis. J. Biol. Chem. 276:32799-32805. http://dx.doi.org/10.1074/jbc.M105431200
31. Osterloh, J.M., J. Yang, T.M. Rooney, A.N. Fox, R. Adalbert, E.H. Powell, A.E. Sheehan, M.A. Avery, R. Hackett, M.A. Logan, et al. 2012. dSarm/Sarm1 is required for activation of an injury-induced axon death pathway. Science. 337:481-484. http://dx.doi.org/10.1126/science.1223899
32. Press, C., and J. Milbrandt. 2008. Nmnat delays axonal degeneration caused by mitochondrial and oxidative stress. J. Neurosci. 28:4861-4871. http://dx.doi.org/10.1523/JNEUROSCI.0525-08.2008
33. Raff, M.C., A.V. Whitmore, and J.T. Finn. 2002. Axonal self-destruction and neurodegeneration. Science. 296:868-871. http://dx.doi.org/10.1126/science.1068613
34. Ryan, K.A., and S.W. Pimplikar. 2005. Activation of GSK-3 and phosphorylation of CRMP2 in transgenic mice expressing APP intracellular domain. J. Cell Biol. 171:327-335. http://dx.doi.org/10.1083/jcb.200505078
35. Saitoh, F., and T. Araki. 2010. Proteasomal degradation of glutamine synthetase regulates Schwann cell differentiation. J. Neurosci. 30:1204-1212. http://dx.doi.org/10.1523/JNEUROSCI.3591-09.2010
36. Sajadi, A., B.L. Schneider, and P. Aebischer. 2004. Wlds-mediated protection of dopaminergic fibers in an animal model of Parkinson disease. Curr. Biol. 14:326-330. http://dx.doi.org/10.1016/j.cub.2004.01.053
37. Taguchi, A., Y. Kasahara, T. Nakagomi, D.M. Stern, M. Fukunaga, M. Ishikawa, and T. Matsuyama. 2010. A reproducible and simple model of permanent cerebral ischemia in CB-17 and SCID mice. J. Exp. Stroke Transl. Med. 3:28-33. http://dx.doi.org/10.6030/1939-067X-3.1.28
38. Tsuchiya, D., S. Hong, Y. Matsumori, H. Shiina, T. Kayama, R.A. Swanson, W.H. Dillman, J. Liu, S.S. Panter, and P.R. Weinstein. 2003. Overexpression of rat heat shock protein 70 is associated with reduction of early mitochondrial cytochrome C release and subsequent DNA fragmentation after permanent focal ischemia. J. Cereb. Blood Flow Metab. 23:718-727
39. Ueda, H., and R. Fujita. 2004. Cell death mode switch from necrosis to apoptosis in brain. Biol. Pharm. Bull. 27:950-955. http://dx.doi.org/10.1248/bpb.27.950
40. Wakatsuki, S., F. Saitoh, and T. Araki. 2011. ZNRF1 promotes Wallerian degeneration by degrading AKT to induce GSK3B-dependent CRMP2 phosphorylation. Nat. Cell Biol. 13:1415-1423. http://dx.doi.org/10.1038/ncb2373
41. Wang, J.T., Z.A. Medress, and B.A. Barres. 2012. Axon degeneration: Molecular mechanisms of a self-destruction pathway. J. Cell Biol. 196:7-18. http://dx.doi.org/10.1083/jcb.201108111
42. Whitmore, A.V., T. Lindsten, M.C. Raff, and C.B. Thompson. 2003. The proapoptotic proteins Bax and Bak are not involved in Wallerian degeneration. Cell Death Differ. 10:260-261. http://dx.doi.org/10.1038/sj.cdd.4401147
43. Williamson, R., L. van Aalten, D.M. Mann, B. Platt, F. Plattner, L. Bedford, J. Mayer, D. Howlett, A. Usardi, C. Sutherland, and A.R. Cole. 2011. CRMP2 hyperphosphorylation is characteristic of Alzheimer's disease and not a feature common to other neurodegenerative diseases. J. Alzheimers Dis. 27:615-625. http://dx.doi.org/10.3233/JAD-2011-110617
44. Yang, J., Z. Wu, N. Renier, D.J. Simon, K. Uryu, D.S. Park, P.A. Greer, C. Tournier, R.J. Davis, and M. Tessier-Lavigne. 2015. Pathological axonal death through a MAPK cascade that triggers a local energy deficit. Cell. 160:161-176. http://dx.doi.org/10.1016/j.cell.2014.11.053
45. Zhong, Q., W. Gao, F. Du, and X. Wang. 2005. Mule/ARF-BP1, a BH3-only E3 ubiquitin ligase, catalyzes the polyubiquitination of Mcl-1 and regulates apoptosis. Cell. 121:1085-1095. http://dx.doi.org/10.1016/j.cell.2005.06.009
46. Zhou, F.Q., J. Zhou, S. Dedhar, Y.H. Wu, and W.D. Snider. 2004. NGF-induced axon growth is mediated by localized inactivation of GSK-3beta and functions of the microtubule plus end binding protein APC. Neuron. 42:897-912. http://dx.doi.org/10.1016/j.neuron.2004.05.011
47. Zille, M., T.D. Farr, I. Przesdzing, J. Muller, C. Sommer, U. Dirnagl, and A. Wunder. 2012. Visualizing cell death in experimental focal cerebral ischemia: Promises, problems, and perspectives. J. Cereb. Blood Flow Metab. 32:213-231